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Abstract
Background: Ethiopia introduced ART (Anti-retroviral therapy) relatively recently, in 2004.
However, the effectiveness of the intervention has not been evaluated. The objective of this
study was to assess the level of adherence among patients enrolled to ART in Dilla Hospital
and determining factors for non-adherence.
Method: A cross-sectional study with internal comparison was conducted among AIDS
patients receiving antiretroviral treatment at Dilla Hospital Systematic sampling method was
used to draw study subjects. Total of 348 study subjects were participated in the study. Data
collection was done from March 20 to April 19, 2009 using structured questionnaires. Then it
was analyzed using EPI-info and SPSS 15.0 version.
Result: The level of ART adherence at Dilla hospital based on multi-method assessment was
77%, while single method alone shown (Self-report 292(83.9%), PIT 291(83.6%) and Pill count
276(79.3%). Disclosure HIV status, knowledge about ART adherence, presence of social
support were associated with ART adherence level AOR (95% C.I) = 4.041(1.721, 9.491),
62.960(23.475, 168.860), and 3.516(1.362, 9.077) respectively.
Conclusion and Recommendations: The lower level of ART adherence is critical problem
and poses challenges on expansion of ART service because of it consequence such as
emerging drug resistance virus which could divert the benefit of ART with high morbidity and
mortality.
An effort should be done for fighting stigma and discrimination through participation of CBOs
(Community Based Organizations), cultural structures like Idirs and strengthens PLHIV
association. Encouraging patients in order to involve family members before and after
initiation of ART treatment is also an important strategy to reduce non-adherence factors.
11. Statements of the problem
HIV is devastating global public health problem with enormous social and economic
consequences. According to estimate from the world health organization the total of 33.2 million
people are infected with HIV (1).
A decade ago, someone living with HIV/AIDS had little hope. The introduction of antiretroviral
(ARVs) since 1996 have dramatically reduced mortality and morbidity, prolonged lives, and
improved the quality of life of many people living with HIV/AIDS (2).
ART don't cure an illness, however; the provision of ART has been credited with having a
significant positive effect on lives of people with HIV/AIDS; improved the rate of mortality and
morbidity, prolong lives, revitalized communities and transformed perception of HIV /AIDS so
that HIV/AIDS is seen as a manageable chronic illness rather than as plague. Therefore,
providing treatment is essential to alleviate suffering and to mitigate the devastating impact of
the epidemic. It also presents unprecedented opportunities for a more effective response by
involving people living with HIV/AIDS, their families and communities in providing care, and it
will strengthen HIV/AIDS prevention by increasing awareness (3).
In high-income countries, where combination antiretroviral therapy became widely available
from 1996 onwards, AIDS related mortality declined markedly for two or three years and has
since stabilized. But it was challenging for developing countries to access ART benefit because
of high drug cost. The World Health Organization (WHO) reported that in sub-Saharan Africa,
in 2002, more than 4 million people needed treatment, but then only 50 000 (less than 1.5%) had
access to it (4).
2On 22 September 2003, the World Health Organization declared the lack of access to
HIV/AIDS treatment a global health emergency and announced its commitment to lead the way
towards an ambitious 3 by 5 target (5).
Due to a variety of ongoing advocacy and lobbying initiatives, the prices of ARV drugs are now
low enough to contemplate scaled-up treatment programs in resource-constrained settings. (4)
Approximately 3 million people in low and middle income countries were receiving
antiretroviral therapy at the end of 2008. Progress in providing access to ARV is accelerating
with nearly one million more people receiving ARVs by the end of 2008 (6, 7).
In 2003, the Government of Ethiopia introduced the ART program with the goal to prolong
lives, restore the mental and physical functions and to improve the quality of life of PLHIV. In
the same year (2003), the MOH, DACA and HAPCO developed the national guidelines on
ART, provided ART training to team of health care providers and free provision of ART started
in 2004 (8).
From the estimated number of 310,000 populations who need antiretroviral therapy the numbers
of individuals receiving antiretroviral treatment as of January 2009 were 132,865 (6, 18).
Dilla Town, the capital of Gedo Zone in SNNPR, has an estimated overall HIV prevalence of
9.3 percent among adult's aged 15 to 49 years. (9). Antiretroviral treatment started at Dilla
Hospital in September 2006. As of March 2009, from the total of 1752 registered for ART, 722
clients were receiving antiretroviral treatment. Currently, 22 trained staffs with professional
mixes of 6 physicians, 4 nurses, 3 druggists, 3 lab technicians and 2 desk clerks are providing
the service in the hospital.
To maintain viral suppression it requires maximum adherence to ART. Adherence encompasses
the extent to which a patient follows instruction & implies understanding, consent &
3partnership. The first-line antiretroviral regimens now being taken in resource-limited settings
are based on nevirapine or efavirenz. Resistance to either drug can develop very easily if doses
are missed, and studies have shown that patients need to take at least 95% of doses in order to
have a good chance of maintaining viral suppression. Drug resistance is a potentially major
threatens to achieve universal access it could mean that more and more people switch to second
line drugs, which are more expensive and more difficult to use (3, 8).
Therefore, this study was designed to identify socio-demographic, cultural and economic
behavioral factors of ART client & other key factors in the community , health facility and
society level contributes to poor adherence to ARV medication with a view to suggest relevant
intervention measures to maintain adherence.
4Figure1: Conceptual frame work: (factors associated to suboptimal
adherence)
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52. Literature review
HAART significantly slowed HIV disease progression, decreased the incidence of opportunistic
infections, significantly reduced hospitalization, and generally improved patients’ quality of life.
Although near perfect adherence (>95%) is required to optimal viral suppression and to prevent
the development and transmission of multidrug strain resistance. Starting patients on ART
without ensuring full adherence is likely to lead treatment failure and the emerging of drug
resistance virus which can be transmitted to others (3, 16).
High adherence rates are necessary to achieve and maintain suppression of HIV replication,
prevent opportunistic infection and death. Full benefit of ART including maximum and durable
suppression of viral replication, reducing destruction of CD4 cells, promotion of immune
reconstitution could be attained by high adherence (10, 12).
Poor adherence, indeed, may lead to medication failure, viral mutations and development of
drug resistance. Future treatment options become limited because of cross-resistance (13).
ARVs drug must be taken for a patients life, and high levels of adherence are required to
maintain the functionality of the individual immune system and to slow the emergency of
resistant strains; hence, it is suggested that 95% adherence is necessary for optimal viral
suppression and to prevent the development of multi-drug resistance HIV virus (1, 12).
A self-administered questionnaire survey conducted in a specialized HIV clinical service in
Hong Cong on 76 Chinese patients who had been on highly active antiretroviral therapy for over
one year showed the majority (76%) scored 100% in self-reporting adherence rating, one –third
of these had in fact missed at least one dose in the preceding four – week period.
6Men having sex with men had a lower tendency of missing dose than heterosexuals (13.6%
versus 42%, P = 0.019). There was no association between missing doses and clinical staging or
the regimens (14).
According study of Brazil, from the total of 1972 ART patients who were interviewed, the
adherence prevalence estimate was 75.05% (95% CI 73.08 – 76.95%). The report revealed that
the variable associated with non-adherence were the educational level (P<0.01). The patients
with fewer years of education were more likely so non-adherent than those with more years of
formal education (15).
According to study result of Botswana; from a total of 515 patients interviewed, using a
structured questionnaire, the optimal adherence rate were: 75% using the pharmacy pill count,
60% using visual line, and 96% using the self-report (two days recall method). The composite of
optimal adherence rate (average of the optimal adherence rate using the three methods) was
estimated to be 77%. The most common reason cited for missed medication in the  study were
forgetfulness (18%), logistics and cost (13%), work and home duties (12%), stigma (7%), lack
of care (4%), lack of food (2%) and alcohol abuse (2%) (16).
Studies done in Ethiopia, Adama and Jimma hospitals, showed that the prevalence of ART
adherence by self report based on recall of previous days duration was 83.2 (17).
A study report by Endrias M. et al at Yirgalem Hospital, south Ethiopia, revealed that the
prevalence of adherence was 88.7%. The reasons for non-adherence cited by patients were;
being busy or simply forgetting (51%), changing in daily routine (9.4%), and being away from
home (8.3%) (18).
7One study done in Rwandan showed that ART found no increase in risky sexual behaviors, but
an obstacle to ART initiation and adherence for 76% of patients was a fear of developing too
much appetite without enough to eat. Access to adequate nutrition may be a major determinant
for long-term adherence to ART (21).
83. Objective
General objective: Assess adherence level among ART users at Dilla Hospital.
Specific objective:
1. To estimate the adherence level among ART users at Dilla hospital.
2. To identify the factors that contributes to non-adherence among ART users at Dilla Hospital.
94. Study Methods
Study design: cross-sectional study with internal comparison was done at Dilla Hospital among
PLHIV (People living with HIV/AIDS) who were receiving ART from March 20 - April 19,
2009.
Study area: Dilla, the capital of Gedeo Zone, in SNNPR is located 360 km south of Addis
Ababa with an estimated population of 63, 205.
The altitude varies between 1250 to 2850 meters above the sea level. The major rainy season is
from July to September and the dry season is from October to January (19).
Source population: Seven hundred twenty two people were on ART at Dilla Hospital as of
March 2009
Study population: The study subjects who were drawn from source of population during data
collection referred as study population. Adults, 18 years or over, whom have been on ART for at
least three months and willing to participate in the study were the source population.
Sample size and sampling technique: From ART registration book the study subjects were
selected by using systematic sampling method. A 95% confidence interval and 3.5% marginal
error was used to obtain the optimum number of sample size. The prevalence of ART adherence
of Dila Hospital was not known, thus, we took ART adherence rate of Yirgalem Hospital (88.7)
to calculate the sample size.
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n = Z2 P (1 – P )
d2
n = 1.962 P (1 – P )
d2
Where:
n = required sample size,
P = prevalence
d = margin of error, thus, we found a sample size of 315 with precision of 3.5%
But to determining level of adherence and to meet the second objective, two proportion formulas
for unmatched case control study assuming ratio of non adherent case to adherent control of 1:3
ratios was used to calculate sample size. According to study of ART adherence at Yirgalem
Hospital, OR of 2.19, 95% CI 1.44 to 5.24 was for individuals who live more than 47 km. The
proportion of individuals who lived more than 47 km was assumed to be 46.5% among non-
adherence and 28.7% among adherence groups. Therefore, by using  available information and
considering availability of patients, in this study we considered OR of 2.19, power 80% and
then optimum sample size was 316 (79 non-adherent and 237 adherent). And also we added
10% contingency for non-response rate, hence, the total of 348 subjects were recruited.
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Sampling method: All patients visiting the site during study period who were age range greater
or equal to 18years, on ART, willing to participate in the study were included in the study. A
systematic sampling method used to draw sample. We drawn a sample daily among those
coming ART clinic and in a case wherever patient was non-interested in being included in the
study, next patient considered.
Adherence measurement tools: Even though some of adherence measurement tools that are
currently used are good, there in no as such a gold standard method in the measurement of
adherence.
The ideal adherence measurement tool should be non-invasive, simple to use, sensitive, specific
and predictive of non-adherence. Studies showed that self–reporting alone is vulnerable to
fabrications, may overestimate adherence. Pill count also could be liable to dumping,
fabrications, and manipulation. This has lead to a multi-method approach that combines feasible
self-reporting, and responsible objective measures (2).
Hence, in this study we applied indirect method of ART adherence measurements such as pill
count, PIT (Pill Identification Test) and client self-report. On top of that structured questionnaire
was used as a tool to assess the challenge regarding ART adherence.
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Multi-method adherence assessment (3,4)
self reporting -Did you stop taking pill during
previous month?
-Did you stop taking pill last 4 days?
- Did you stop taking Pill
During illness improved?
If the answer is no to all  no
for all
questions,
we classified
as Adherent
-If the answer is  yes to one
or more question, we classified
as non-adherent
PIT -Client knows Dose of medication
-Knows  timing (frequency) of
Medication
- if the answer
is yes to
all , we   classified
as adherent
-If the answer is no to one or
more we classified as non adherent.
Pill count 95% or more -If 95% or
more we
classified as adherent
- If less than 95%, we
classified as non adherent.
overall adherence Adherent Non-adherent
Interpretation of adherence measurements:
If all the results appear in the same column e.g. all no for self report, pill count 95%, dose and
time for PTI, then, we counted this client as adherent for the overall adherence level
classification.
But if when the result don't line up in a single vertical columns, they spread over two column, or
line up in right column we classified this client as non adherent.
Data collection: After obtaining Ethical clearance from University of Gondor Ethical
committee, the data collectors were recruited and given one day training. Data collocation took
30 days from March 20 – April 19, 2009. Four trained nurses collected the data and fill the
questionnaire. One nurse interviewed maximum of 5 study subject a day by selecting every 2nd
clients from registration desk.
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Quality control: Data collection tool (questioner) adapted from different literatures, text books
and from the conceptual frame work for ART adherent. The questioners were translated to local
language (Amiharic). We consulted university of Dilla Department of psychology to check its
validity of translation. To maintain accuracy and consistency of data four nurses recruited from
Dilla Hospital as data collectors and, one day training was given for them. Before actual study
commencement the research team conducted to pretest instrument and questionnaire with 10
clients at Yirgachefe Health Center, and then we discussed and made necessary revision of the
questionnaires. The pretest served to rectify or correct some questionnaires. During data
collection meticulous supervision was done by principal investigator to check whether data
collections and sampling procedure was running as intended or not. Finally, collected data were
cleaned and checked for its completeness and consistency.
Data analysis and interpretation: After checking the collected data for completeness and
consistency, data were entered to EPI-info 3.5.1, and then analysis was done using SPSS 15.
Frequency, percentage and multivariate analysis was carried out. Bivariate and multivariate
analysis was done using logistic regression. Significant test was determined using, 95% C.I of
adjusted and crude odds ratio (OR) for which, PV<0.05 were considered statistically significant.
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5. Ethical consideration
Ethical clearance was obtained from University of Gondor and Addis Continental Institute of
Public Health Research Ethical committee. And also permission obtained from Zonal Health
Department and Dilla Hospital before commencement of study. Clients were verbally informed
about the aim of study. The right of study subject was respected if they didn't want to give
information at a time before or during interaction. The study didn't cause any risk on study
subject. The collected data were locked and only accessed by principal investigator.
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6. Result
A total of 348 clients were participated in the study. There is a higher proportion between male
and female who enrolled for ART, 220 (63.2%) females and 128(36.8%) males. About 52%
(182) of the respondents were between the ages 25-31 years. The majority of ART users,,
216(62.1%) were Orthodox Christians, 174 (50%) were married and 115 (33%) Amahara ethnic
group. About eighty two percent of study group earn monthly income of less than 300 ETBirr.
From the total respondents, 42 (12.1%) of study subject were unable to read and write, 257
(73.9%) attended primary education and 49 (14.1%) completed secondary school. A total of 323
(92.8%) were from urban and the remaining 25 (7.2%) from rural areas. Out of 384 study
subjects, only 20 (5.8%) came from greater than 47 km to refill monthly pills. Regarding
occupation, 156 (44.8%) clients reported that they are daily laborers. (Table 1)
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Table 1: Socio-demographic characteristics of ART users and ART adherence level at Dilla Hospital, March - April
2009, South Ethiopia.
Variables
Adherence status
Total
N (%)
Adhere to the drug
N (%)
Not adhere to the drug
N (%)
Sex Male 103(80.5%) 25(19.5%) 128(100%)
Female 165(75%) 55(25%) 220(100%)
25(67.6%) 12(32.4%) 37(100%)Age 18-24yrs
25-31 144(79.1%) 38 182(100%)
32-48 82(78.8%) 22(21.2%) 104(100%)
>=49yrs 17(68%) 8(32%) 25(100%)
167(77.3%) 49(22.7%) 216(100%)Religion Orthodox
Muslim 24(72.7%) 9(27.3%) 33(100%)
Protestant 72(76.6%) 22(23.4%) 94(100%)
Others 5(100%) 0(0%) 5(100%)
251(77.7%) 72(22.3%) 323(100%)Place Urban
Rural 17(68%) 8(32%) 25(100%)
57(79.2%) 15(20.8%) 72(100%)Ethnicity Gedeo
Amara 85(73.3%) 31(26.7%) 116(100%)
Oromo 45(77.6%) 13(22.4%) 58(100%)
Gurage 35(85.4%) 6(14.6%) 41(100%)
Others 46(75.4%) 15(24.6%) 61(100%)
131(75.3%) 43(24.7%) 174(100%)Marital Married
status Unmarried 48(78.7%) 13(21.3%) 61(100%)
Widow(ed) 58(78.4%) 16(21.6%) 74(100%)
Divorced 31(79.5%) 8(20.5%) 39(100%)
Educational Illiterate 34(81%) 8(19%) 42(100%)
Primary education
Secondary & above
62(24.1%)
10(20.4%)
195(75.9%)
49(79.6%)
257(100%)
49(100%)
Distance <47km 255(78%) 72(22%) 327(100%)
Residence >=47km 12(60%) 8(40%) 20(100%)
222(77.9%) 63(22.1%) 285(100%)Monthly <300birr
income 300-500birr 38(70%) 16(29.6%) 54(100%)
500-1000birr 5(83.3%) 1(16.7%) 6(100%)
>1000 3(100%) 0(0%) 3(100%)
31(19.9%) 156(100%)Occupation Day laborer 125(80.1%)
Student 11(73.3%) 4(26.7%) 15(100%)
Government employee 14(73.7%) 5(26.3%) 19(100%)
Merchant 63(76.8%) 19(23.2%) 82(100%)
Others 55(72.4%) 21(27.6%) 76(100%)
77.0% 23.0% 100.0%
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The majority of study subjects 322 (92.5%) responded that ART reduce replication of HIV,
while the remained 26 (7.5%) believed that ART cures HIV/AIDS. Two hundred and ninety five
(85%) of study subjects have known that ART drug being given for life long, but 51 (14.7%)
responded that the treatment duration will be decided by physician and one respondent said he
would take for one year. From the total of study subjects 112 (32.2%) claimed that they faced
side effect of drug at least once with in the last one year.  Disturbance of sleep, nausea, skin
rash, heart burn, headache, etc were the common side effects reported by the respondent. All
respondents answered that they visited doctor when they faced such problems (Table 2).
Table 2: Descriptive statistics for some variables on ART adherence at Dilla Hospital, March
2009, Southern Ethiopia,
Variables Number Percentage
ART benefit
Reduce  viral replication 322 92.5
Cure HIV/AIDS 26 7.5
Clients knowledge on duration of RX
Life long 297 85.3
Decided by Physician 51 14.7
Knowledge on ART adherence
Satisfactory 291 83
Unsatisfactory 57 17
Drug combination
FDC 281 80.7
Un combined drugs 67 19.3
Drugs side effect
Yes 112 32.2
No 272 67.8
Disclosure status
Yes 281 81.1
No 66 18.9
Get support in the community
Yes 295 84.8
No 53 15.2
18
The level of adherence based on multi-methods assessment was found to be 77%, while based
on single method includes: Self-report 292 (83.9%), PIT 291 (83.6%) and Pill count 276
(79.3%) (Table 3).
Table 3: Percent of respondent with optimal ART adherence rate of ART users at Dilla Hospital,
March - April 2009, Southern Ethiopia
Tools Adhere to drug
N (%)
Non-adhere to the drug
N (%)
Self reporting 292(83.9) 56(16.1)
PIT 291(83.6) 57(16.4)
Pill count 276(79.3%) 72(21.7)
Overall
adherence
268(77) 80(23)
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Not adhere to the drug
Adhere to the drug
23%
77%
Figure 2: Adherence level among ART users at Dilla Hospital, south
Ethiopia, March - April 2009
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The common reasons for missing dose cited on this study were: forgetfulness 43 (54.4%), lack
of food 14(17.7%), too busy 8 (10.1%), transportation problems 6 (7.6%), away from home 2
(2.5%), tebel(holy water) 3 (3.8%) (Figure 3).
Figure 3: Reasons for missing drugs as stated by ART clients at Dilla Hospital, March 2009,
Southern Ethiopia, March 2009
In accordance to self-report, 49 (14.1%) missed one or more medication dose on any given day
in previous month because of various reason, about 27 (7.8%) reported that they missing dose in
the past four days, while 13 (3.8%) clients reported that they missed dose when they feel better.
Reasons
tebel/fastingTransportation
problem
Away from
home
Too busySide effectLack of foodForgetfulness
Percent
60
50
40
30
20
10
0
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Disclosure HIV status, knowledge about ART adherence, presence of social support were
associated with ART adherence level AOR (95% C.I) = 4.041(1.721, 9.491), 62.960(23.475,
168.860), and 3.516(1.362, 9.077) respectively.
Among the total of 384 respondent 281(81%) have disclosed their HIV status for others, while
the remaining 66(19%) have not disclosed thiere HIV status for others. The main reason for non
disclosure fear of stigma and discrimination 51(75%) and non-adherence was more common
among those who didn't disclose their status. Almost all 343(99.6%) of clients responded that they
had good relationship with Hospital ART team.
Two hundred ninety two (83.9%) of the stud subject had got social support in their community
or CBO and they were more adherent than those who didn't get the support.
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Table 4: Association of variable with adherence status among study participants at Dilla
Hospital, March 2009, Southern Ethiopia,
Variables Adherence status
Odds ratio (95%C.I)
Not adhere to the drug
N
Adhere to the drug
N
Crude Adjusted
Sex
Male
Female
25
55
103
165
1.373(.806, 2.340)
1
1.698(.781, 4.064)
1
Age
18-24yrs
25-31yrs
32-48yrs
+48yrs
12
38
22
8
25
144
82
17
.695(.107, 4.515)
.939(.201, 4.382)
.691(.139, 3.434)
1
.980(.331, 2.905)
1.783(.716, 4.444)
1.754(.670, 4.595)
1
Educational status
Illiterate
Primary education
Secondary & above
8
62
10
34
195
39
1.090(.386, 3.075)
.806(.380, 1.709)
1
4.017(.825, 20.659)
1.824(.658, 5.055)
1
Distance Residence
>=47km 8 12 2.361(.930, 5.997) .950(.196, 4.598)
<47km 72 255 1 1
ART benefit
Prevent viral
replication
Cure
71
9
751
17
1.870(0.800, 4.370)
1
.691(.165, 2.883)
1
Adherence
knowledge *
Satisfactory
Unsatisfactory
30
50
261
7 62.14(24.31, 165.92)
1
62.960(23.475, 168.860)
1
Drug category
FDC
Uncombined
61
19
221
47
1.465(.801, 2.678)
1
1.209(.498, 2.933)
1
Drug side effect
No
Yes
48
32
188
80
.638(.380,1.072)
1
.412(.189, .897)
1
Clients HIV
disclosure status  *
Yes
No
50
30
231
36 3.850(217, 6.810)
1
4.041(1.721, 9.491)
1
Get support in the
community *
Yes
No
52
28
243
25 5.230(2.820, 9.690)
1
3.516(1.362, 9.077)
1
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7. Discussion
In this study the level of ART adherence based on multi-method assessment was found to be
77% while based on single method includes: Self-report 292(83.9%), PIT 291(83.6%) and Pill
count 276(79.3%).  In accordance to self report 14.1% of patients missed one or more
medication in previous month, 7.8% missed doses in past four days and while 3.8 % missed
doses when they feel better. This study revealed that knowledge on ART adherence, disclosure
of HIV status and presence of support in the community were strongly associated with ART
adherence. The main reason for non-discloser was fear of stigma and discrimination (57%). The
most common reasons for missing dose cited were forgetfulness, lack of food, too busy,
transportation problems, away from home, using tebel (holy water).
The level of ART adherence is somewhat lower than the previous studies done in Ethiopia. But
if we see self report alone ART adherence rate is almost identical to study report of Adama and
Jimma Hospital (83%). Therefore lower prevalence could be explained by the methods of
adherence assessment. Many researchers prefer self report to assess level of adherence due to
that it is cheap and applicable, however, it usually prone to overestimation. With this study we
used multi-method ART adherence: Self report, PIT, and Pill count. Even though pill count  and
pill identification are not golden standard, they could give additional information. On the other
hand it showed that adherence level is a bit better than developed countries, for instance the
average figure in USA was 70%. (3) In Africa studies, adherence levels reported range from 54-
94% depending on the measures used: Botswana (Weiser et al, 2003: 54%), Nigeria (Daniel,
2004: 79%), South Africa (Ferris et al, 2004: 77%), and Uganda ( Munganzi, 2004: 98%), etc.
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However, this study revealed that there is good relationship between ART users (clients) and
Hospital ART team, (16.4%) of clients didn't have satisfactory knowledge on ART adherence
and lack of satisfactory knowledge on ART adherence was associated with non-adherence.
Therefore, preparing patients before ART initiation, involvement in therapeutic decision and
reluctant not to counsel the client during follow up is very important to minimize non-adherent
rate.
Clients who didn’t disclose their HIV status were more likely to be non-adherent and it may
suggested  that if patients don’t disclose HIV status for family or partner they couldn’t get
reminder for medication time in the family since certain literature agreed  that availing reminder
in the family is a solution to conquer forgetfulness. Negotiating with clients in order them to
disclose their status, establishing or referring them to peer group may be important.
The presence of social support in the community also has strong association with ART
adherence. Provision of treatment alone will not guarantee to achieve intended objectives ,in
accordance to study subjects’ response, lack of food was on of the reason for missed dose; it
means that if they get care and support in the community adherence level may be improved.
Therefore an effort to access community support through integrating and strengthen support
group, link them with community based organization and mobilizing cultural structure like Idirs
for care and support may help in averting such problems.
On other studies, factors for positive predictors were ; patient residence near by health institutes,
free of adverse effect, patient belief on of HAART, presence of social support. Distance of
residence has no effect in this study probably because accessibility of ART service has increased
currently. Patients might have accepted adverse effect comparing AIDS morbidity with positive
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drug effects such as improved their health physically, mentally and socially. Therefore, in this
study they might have underreported the symptom of drug side effect.
In line with this study, the similar reasons were also reported for missing doses in Ethiopia and
other Africa studies. Missed doses of ART were due to forgetfulness, lack of food, too busy,
transportation problems, away from home, using tebel (holy water).
We used multi-method adherence assessment approach (self-report, PIT, pill count) that could
be strong point of this study. And also an effort was done to avoid bias met it quality ;  data
collectors trained, used standard questioners, conducted pilot study and discussed before actual
data collection . However, it has it own short coming; few patients didn't bring pill during
monthly visit and in that case we used self estimation that could prone to recall bias.
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8. Conclusion and Recommendations
8.1. Conclusion:
The lower level ART adherence is critical problem and poses challenges on expansion of ART
service because of it consequence such as emerging drug resistance virus which could divert the
benefit of ART with high morbidity and mortality.
8.2. Recommendations:
The finding supported that informing, preparing and educating patients before initiation of
antiretroviral therapeutic decision should be seen as armour to narrow ART adherence gap.
An effort has been taken for fighting stigma and discrimination through participation of CBOs,
cultural structures like Idirs and strengthens PLHIV association.
Integrating and strengthen support group; this peer groups will develop relationship with patient,
will discuss on challenging issues, help to retain patient in the care and  to identify missed client
earlier.
Encourage client in order to involving family members before and after initiation of ART
treatment is an important strategy to reduce non-adherence factors.
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11. Annex
11.1. Consent form
My name is ---------------- I am collecting information about ART challenges ‘Assessment of
ART adherence at Dilla Hospital among ART users’.
Information gathered from this questioner will not be released to any other parties and all
information will be kept confidential. And also you can cancel giving information at any time if
you feel inconvenience. Please be aware that all information you provide is relevant and very
important,
Therefore, do you agree
1. yes
2. no
11. 2. Questionnaire
Gondor University and Addis Continental Institute of Public Health
School of Graduate studies
Section I: socio- demographic characteristics
1.Sex 1.male
3. female
2. Age 1. 18 – 24
2. 25 - 31
3. 32 - 48
4. >=49
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3.Religion: 1.Orthodox,
2. Muslim,
3. Protestant,
4. others
4. place 1. town
2. Rural
5. Ethnicity 1.Gedeo
2. Amara
3. Oromo
4. Gurage
5. others, specify
6.Marital status 1. married
2. Unmarried
3. Widowed(er)
4. divorced
7.Educational status
8.Distance from Health facilities
9.monthly income
1. illiterate
2. primary education,
3. Secondary education &above
1.>47km
2.<=47km
1.<300birr
2.300-500birr
3.500-1000birr
4.>1000birr
10. Occupation 1.Day laborer
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2.Student
3.employe
4. merchant
5.other, specify
Section II: ART perception and practice
11. what do you think about ART drugs benefit 1.ART prevent disease progression
2. cure HIV/AIDS
12. For how long does it be taken? 1.one year
2.as prescribed by doctor
3.life long
13. Knowledge on Adherence
NB:
good : If clients Know; Right Drug, Right dose, Right time
Unsatisfactory: If clients know not Right Drug, Right dose, Right
time
1.  good
2. unsatisfactory
14. For how longer time have you been on ART? 1. 3 – 6moths
2. 7-12 months
3.13 – 24 months
4. >24 months
15. Mention the drugs that you are taking 1.Fixed combination dose
2.uncombined dose
16. Are there any other medications that you are
taking?
1.yes
2. no
17.If yes , what type of medication are taking 1.Traditional medication
2.prescribed from hospital /health institutes
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18. Have you ever felt drug side effects? 1.yes
2. no
19.if yes,  mention 1.rash
2.nausia
3.headahce
4.heart burn
5.disturbance of sleep
6. others
20. If you feel drugs side effect, what are you going? 1. stop pill
2.visit nurse /Doctor
Section III. Adherence assessment:
A. Self report
21. We appreciate how difficult it can be to take pill on daily basis.
Did you sometimes difficult to take your
medication during last month?
1Yes.
2. No
22. When you feel better, do you sometimes stop
using your medication?
1.yes
2.No
23. Think back over the past 4 days. Would you say
that you have missed any of your doses?
1.yes
2.no
24. over all Self report result/adherence
NB: 1.High :  all no
2. Moderate : 1-2 yes
3. low :  >2yes
1.Highall
2.moderate
3.low
B. Pill identification Test (PIT)
Ask the client to inspect each container and its contents. He or she
should then tell you the name of medication, number of pills to take
per dose, the time he or she takes the medication, and whether there
are any additional instructions.
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25. Knows the dose of medication 1.yes
2.no
26. Time the medication is taken 1.yes
2.no
27. Knows additional instruction, if there is. 1.yes
2.no
28. Over all PTI result
NB:
1.High : Dose, time and instruction
2. Moderate: Dose and time
3. low : dose only or confused
1.High
2. Moderate
3. low
C. Pill count
29. Did the client return the medication? 1.yes
2.no
30. ART adherence based on pill count result
NB:
1.High: 95% or more
2.Moderate:75-94%
3. Low: < 75%
1High
2.Moderate
3.Low
31.Over all adherence based on Multi-method 1.High
2.moderate
3.law
32. client adherence status
NB:
1.Adhere to the drug
2. not adhere to the drug
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1.Adhere to the drug: high on multi-method
2.not adhere to the drug: moderate and low on multi-method
33. Based on above information,
Please can you tell me the reason for missing doses?
1.forgetfulness
2.lack of food
3.side effect
4.too busy
6.away from home
6. Transportation problem
7.'Teble' / fasting
Section IV. Disclosure and networking with others
34.Did you disclosed HIV status to others 1. yes
2. no
35. If not , what is the reason 1. Fear of stigma and discrimination
2.Personal interest
36. Did you have good relationship with hospital ART staffs? 1.Yes
2. no
37. are you supported by home based care program 1. yes
2. no
38. if yes, mention the organization 1. Tesfagoh
2. Medan Acts
3. others
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11.3. Amiharic translations:
የደንበኛው(ዋ) መተማመኛ ቅጽ:
እኔ -------------- እባላለሁ፤ በጎንደር ዪንቨርሲቲ ህብረተሰብ ጤና ሳይንስ ክፍል የድህረምረቃ
ተማሪ ነኝ ፤ስለ ፀረ-ኤች ኣይ ቪ መድኃኒት ቁርኝት በዲላ ሆስፒታል፤ መዲሃኒቱን
በሚጠቀሙ ሰዎች የመድኃት ቁርኝት  እንዳይኖር ሰለሚያደርጉ እንቅፋቶች ኣንዳንድ
ጥያቄዎችን እጠይቅዎታለሁ፡
የእርስዎ ስም በምንም መልኩ አይገለፅም ፤ምስጥርነቱም የተጠበቀ ነው
እርሶ የምሰጡት ምላሾች  በጣም ጠቃሚ ስለሆኑ እንደሚተባበሩ አስባለሁ፡፡
ስለዚህ እንዲጠይቅዎት ፈቃደኛ ነዎት
1. አዎ ፈቃደኛ ነኝ
2. ፈቃደኛ አይደለሁም
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በአማርኛ የተተረጎሙ መጠይቆች:
1.ጾታ 1. ወንድ
2. ሴት
2. እድሜ 1. ከ18 – 24ዓመት
2. 25 – 31ዓመት
3. 32 – 48ዓመት
4. 49 ዓመትና ከዚያ በላይ
3. ሃይማኖት 1.ኦርቶዶክስ
2. ሙስሊም
3. ፕሮቴስታንት
4. ሌሎች
4. የመጡበት ቦታ 1.ከከተማ
2.ከገጠር
5. ብሔረሰብ 1.ጌዲኦ
2. አማራ
3. ኦሮሞ
4. ጉራጌ
5. ሌሎች
6.የትዳር ሁኔታ 1.ያገባ
2. ያላገባ
3.የሞተበት(ባት)
4. የፈታች(ታ)
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7.የትምህርት ሁኔታ
8.ከጤና ድርጅቱ  ደመበኛው የሚኖርበት(የሚትኖርበት) ረቀት
9.የወር ገቢው(ዋ)
1. ያልተማረ(ች)
2.የመጀመሪያ ደረጃ
3. ሁለተኛ ደረጃና ከዚያበላይ
1.ከ47ኪሜ በላይ
2. 47ኪሜና ከዚያ በታች
1.ከ300ብር በታች
2. ከ300-500ብር
3.ከ500-1000ብር
4.ከ1000ብር በላይ
10. ስራ 1.የቀን ሰራተኛ
2.ተማሪ
3.የመንግስ ሰራተኛ(ተቀጣሪ)
4. ነጋዴ
5.ሌሎች
11. ስለ ፀረ ኤች ኣይ ቪ መዲሃኒት ጥቅም ያልዎት አመለካከት 1.የቫይረሱን ስርጭት ይገታል
2. ከኤድስ ያድናል
12. መድሃኑቱ መወሰድ ያለበት ለምን ያህል ጊዜ ነው? 1.ለአንደ አመት
2.እንደ ሀኪሙ ትእዛዝ
3እድሜ ልክ
13. ደንበኛው(ዋ) ስለዘለቄታዊ የመድሃኒት ቁርኝት ምን ያህል
ያውቃል(ታውቃለች)
ማሻ:
አጥጋቢ : ከ1-3 ከዚህ በታች የተጠቀሱትን ከመለሰ(ች)
1. ተገቢ መዲሃኒቶች መውሰድ
2.በተገቢ ሰአት ሳያቁዋርጡ መውሰድ
1. አጥጋቢ
2. አጥጋቢ አይደለም
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3.በተገቢ መንገድ መውሰድ
አጥጋቢ አይደለም: ሶስቱንም በትክክል ካልመለሰ(ች)
14. እስካሁን መድሃኒቱን ለምን ያህል ጊዜ ወስደዋል? 1. ከ3 – 6ወራት
2. ከ7-12ወራት
3. ከ13 – 24 ወራት
4. ከ24 ወራት በላይ
15. የሚወስዱትን መድሃኒቶች ይጥቀሱ
መሸ፡ ጥምር- ሶስት በአንድ
1.ጥምር መድሃኒቶች
2.ጥምር ያልሆኑ መድሃኒቶች
16.ሌሎቸ የሚወስዱት መድሃኒቶች አሉ? 1.አዎ አሉ
2.የሉም
17. መልሱ አዎ ከሆነ ምን አይነት መድሃኒቶች 1.ባህላዊ
2. በሃኪም የታዘዘ
18. የጸረ-ኤች ኣይ ቪ መድሃኒቶች የጎንዮች ጉዳት አጋጥምዎት ያውቃል? 1.አዎ
2. አላጋጠመኝም
19. አዎን ከሆነ ይጥቀሱ 1. የቆዳ ማሳከክ
2.ማቅለሽለሽ
3. ራስ ምታት
4. ማቃጠል/ቃር
5.እንቅልፍ ማዛባት/ማቃዠት
6. ሌሌች
20. የጸረ-ኤች ኣይ ቪ መድሃኒቶች የጎንዮች ጉዳት ሲያጋጥምዎት ምን
ያደርጋሉ?
1. መዲሃኒቱን ኣቁዋርጣለሁl
2.ሀኪም አማክራለሁ
21. በየእለቱ መዲሃኑቱን በተከታታይ መውሰድ ምን ያህል አስቸጋሪ
እንደሆነ እናውቃለን፡ ባለፈው ወር ውስጥ መድሃኒቱን ያቁወረጡበት ጊዜ
አለ?
1አዎ .
2. አይደለም
22. ስሻልዎት (ጤነኛነት ስሰማዎት) መድሃኒቱን ያቁዋረጡበት ጊዜ አለ? 1አዎ .
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2. አይደለም
23. እሰቲ ወደሁዋለ አራት ቀናት አስቡመድሃኒቱን ያቁዋረጡበት ጊዜ አለ 1አዎ .
2. አይደለም
24. ከላይ ከ21 – 23 በተሰጡት ምላሾች መሰረትየ የመድዲሃኒት
ቁርኝቱ
ማሻ: 1. ከፍተኛ፤ ሁሉም መልሶች አይደለም ከሆኑ
2. መከከለኛ : ከ1-2 መልሶች አዎን ከሆኑ
3. ከ2 በላይ መልሶች አዎን ከሆኑ
1.ከፍተኛ
2.መካከለኛ
3.ዝቅተኛ
25. ደንበኛው ስለመድሃኒቱ ስም በትክክል ያውቃሉ 1.አዎ
2.አይደለም/አያውቁም
26. ደንበኛው መዲሃኒቱ የሚወሰድበትን ሰአት በትክክል ያውቃሉ 1.አዎ
2.አይደለም/ አያውቁም
27. ደንበኛው ተጨማሪ ስለመዲሃኒቱ መመሪያ በትክክል ያውቃሉ/
መመሪያ ካለ/
1.አዎ
2.አይደለም /አያውቁም
28. ከላይ ከ25 – 27 በተሰጡት ምላሾች መሰረት የመድዲሃኒት ቁርኝቱ
ማሻ: 1. ከፍተኛ ሁሉን በትክክል ካወቀ
2. መከከለኛ : ከ1-2 መልሶች ካወቀ
3 .ሁሉን አይደለም ካለ
1.ከፍተኛ
2.መካከለኛ
3.ዝቅተኛ
29. እስቲ ከታዘዎት መድሃኒትቶች የተመለሰ አለ? 1.አዎ
2.አይደለም
30. በተመለሱትመድሃኒቶች ቁጥር መሰረት የደበኛው (ዋ) የመድሃኒት
የቁርኝት ሁኔታt
ማሻ:
1.ከፍተኛ: 95% ና ከዚያ በላይ
2. መካከለኛ:ከ75 እሰከ 94%
3. ከ 75% በታች
1.ከፍተኛ
2.መካከለኛ
3.ዝቅተኛ
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31. ከላይ ከ29 – 30 በተሰጡት ምላሾች መሰረት የመድዲሃኒት ቁርኝቱ 1. ከፍተኛ
2.መካከለኛ
3.ዝቅተኛ
32. በሶሰቱም የቁርኝት መለከያ መሰረት የመድሃኒት ቁርኝት
ማሻ:
1. የመዲሃኒት ቁርኝት፤ በሁሉም የቁርኝት መስፈርቶች ከፍተኛ ከሆነ
2. ቁርኝት የለውም(ትም) ፡ ከሶሰቱ መለኪያዎች በአንዳቸው እንኩዋን
መከከለኛ ወይንም ዝቅተጠኛ ከሆነ
1.ደንበኛው(ዋ) የመድሃኒት ቁርኝት አለው(ላት)
2..ደንበኛው(ዋ) የመድሃኒት ቁርኝት
የለውም(የላትም)
33. ደንበኛው(ዋ) የ መዲሃኒት ቁርኝት እንዳይኖርበት(ባት) ምክንያቶች
የሆኑ?
1.መርሳት
2.የምግብ እጥረት
3.የጎንዮሽ ጉዳት
4. የስራ ብዛት
5. ከቤት እስከ ሆስፒታል ያለ ርቀት
6.የመጉዋጉዋዣ ችግር
7.ጠበል
34.በደምዎ ኤች አይ ቪ እንዳለ ከሌሎች ጋር ይወያያሉ 1.አዎ
2.አይደለም
35. መልስዎ አይደለም ከሆነ ምክንያት 1. መድልዎን በመፍራት
2.ራሴን ላለመግለጽ
36. ክትትል ከሚያደርግልዎ የጤና ባለሙያ ጋር የለዎት ግንኙነት
/ክትትል ጥሩ ነው ብለው ያስባሉ?
1.አዎ
2.አይደለም በጥሩ ሁኔታ አያስተናግድም(ዱም)
37. በአከባቢዎ በህሙማን ድጋፍና ክብካቤ ታቅፈዋል(ይረዳሉ) 1.አዎ
2.አይደለም
38. አዎን ከሆነ ድረጅቱን /ማህበሩን ይጥቀሱ 1. ተስፋ ጎህ
2. መዳን አክትስ
3.ሌሎች
